NASDAQ · Medical - Devices

HSCS (HSCS) Stock

$2.18 +4.81% NASDAQ: HSCS Healthcare

Valuation

MetricValue
Price$2.18
Market Cap$4.71M
P/E Ratio-0.70
P/B Ratio3.33
P/S Ratio0.07
EPS (TTM)$-9.34
52-Week High$6.47
52-Week Low$1.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-498.03%
ROA-167.79%
ROCE-500.09%
Gross Margin-10.60%
Operating Margin-899.40%
Net Margin-14.16%
Debt/Equity1.46
Current Ratio0.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-5.0M$-6.0M$-6.0M$-8.0M
Net Profit$-2.0M$-5.0M$-6.0M$-7.0M$-9.0M
EPS$-77.89$-137.94$-6173.88$-18.74$-9.34
Op Margin-10030.2%-32765.6%-118698.3%-33902.0%-192013.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$2.0M$3.0M$10.0M$4.0M
Total Liabilities$4.0M$8.0M$3.0M$2.0M$4.0M
Cash$1.0M$1.0M$2.0M$6.0M$1.0M
Borrowings$3.0M$6.0M$2.0M$1.0M$3.0M

Latest News

Zcash Miner Fortitude Merging with HeartSciences to Go Public Exec Edge · Jun 23, 2026 Top Midday Gainers MT Newswires · Jun 23, 2026 BC-Most Active Stocks Associated Press · Jun 23, 2026 HeartSciences to Merge With Digital Asset Mining Platform Fortitude; Shares Rise Pre-Bell MT Newswires · Jun 23, 2026 Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets Business Wire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-6.0M$-7.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$0$0$1.0M$4.0M$-5.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-208.94
FCF Yield152.50%
Quick Ratio-152.97
Interest Coverage-8.00
Return 1Y-35.68%
Return 3Y-97.31%
Return 5Y—

Ownership

Insiders Held23.24%
Institutions Held6.56%
Institutions Float Held8.54%
Institutional HolderSharesReport Date
DRW Securities, LLC76,4502026-03-31
TFB Advisors LLC29,7402026-03-31
Geode Capital Management, LLC28,9382026-03-31
Astoria Strategic Wealth, Inc.18,9272026-03-31
Vanguard Capital Management LLC17,9682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMIX $12.10 -37.95% -0.17 $6.57M 0.00%
BCLIBrainstorm Cell Therapeutics Inc. $0.98 +6.52% -1.04 $10.81M 0.00%
BMRA $1.61 +1.26% -1.09 $4.98M 0.00%
GBSGBS Inc. $0.47 -1.58% -0.18 $433577 0.00%
IBO $0.43 -2.27% -1.61 $5.38M 0.00%

About HSCS

HSCS is led by CEO Andrew Simpson, employs 15 people, headquartered in US, publicly traded since 2022.

HSCS stock trades at $2.18 with a market capitalization of $4.71M. The stock is valued at a price-to-earnings (P/E) ratio of -0.70, price-to-book of 3.33, price-to-sales of 0.07. Over the past 52 weeks the stock has ranged between $1.63 and $6.47, and currently trades 66.3% below its 52-week high.

On profitability, HSCS generates a return on equity (ROE) of -498.03%, return on capital employed of -500.09%, an operating margin of -899.40%, a net profit margin of -14.16%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides